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Mortality associated with foodborne bacterial gastrointestinal
infections
Statistical method is worth examining
Editor—Helms et al report a significant
association between common foodborne
infections, including campylobacteriosis,
and increased short term and long term
mortality.1 As this conflicts with conven-
tional clinical wisdom,2 it is worth scrutinis-
ing the statistical method supporting the
claim.
Helms et al compare ill cases with
healthier (general population) controls by
using a comorbidity index to adjust for the
fact that underlying conditions were more
common among patients than in the control
group, particularly AIDS related illness,
metastatic cancers, and lymphomas or
leukaemia. But even after adjusting for
comorbidity, the relative mortality fell only
from 3.10 to 2.56.
Both the small impact of comorbidity
adjustment and the association between
infections and morbidity can be explained
by known limitations of the Charlson
comorbidity index. For example, for lung
cancer survival, the Charlson index
explained only 2.0% of the variation in
survival.3 It has not been validated for
gastrointestinal infections in AIDS and
leukaemia patients. Thus Helms et al rely on
an index that accounts for relatively little of
the variance in mortality rates. They
attribute the remainder to bacterial patho-
gens. But underlying illness provides a more
plausible explanation.4
Severe illness predicts increased mor-
tality, infections, and comorbidity. The comor-
bidity index does not fully reflect mortality
consequences of illness, so residual con-
founding by illness, even after conditioning
on the index, creates a statistical association
between infection and mortality, although the
former does not cause the latter.
Imperfectly controlled residual con-
founding can explain counterintuitive
statistical associations between exposures
and health outcomes.5 Before accepting that
infectious diarrhoea triples death rates, as
Helms et al say, it is appropriate to consider
more carefully the non-causal association
between infection and mortality from
incompletely controlled confounding.
Louis Anthony Cox Jr president
Cox Associates, 503 Franklin Street, Denver,
CO 80218, USA
Competing interests: LC has conducted research
since 1999 on campylobacter causes and risk
analyses. This work has been partly supported by
funds received from the US Food and Drug
Administration and from the Animal Health
Institute. This comment reflects the author’s
opinions only, and has not been supported by
any funders.
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Case selection and clinical data are
important
Editor—The article by Helms et al raises
the importance of case selection and clinical
data on the estimates of short and long term
mortality from clinical illness.1 Clinicians’
understanding of an illness entails identify-
ing symptoms and signs, in relation to age,
sex, and geography, the three variables for
which the authors selected controls. But cli-
nicians also decide on the necessity for diag-
nostic laboratory tests. Results deemed
unlikely to influence patients’ management
or outcome affect the likelihood of investiga-
tion.2 Variations in laboratory testing proto-
cols and methods affect what is detected and
reported.3
Medical epidemiologists are aware that
the infecting dose affects severity. In general,
the larger the infecting dose, the more
severe the illness and the more likely the
patient is to present to a clinician,4 so that
severe illnesses are more likely to be
represented in those studied.
Medical microbiologists are aware, as
acknowledged by the authors, that among
the several thousand different salmonellas,
some, such as Salmonella typhi, S choleraesuis,
S dublin, and S virchow seem predisposed to
severe illness and bacteraemia. Similar
variation in severity occurs with Shigella and
Campylobacter.
One way to deal with the estimate of
short and long term mortality is to obtain
clinical information concerning mortality.
Helms et al think that deaths occurring
within one year may relate to the bacterial
cause of illness. If a review of the death cer-
tificates might give an incomplete picture,
examining hospital records could reduce
the difficulty.
The method used, as suggested by
Evans’s commentary,1 relates to estimates of
an exposure that affects mortality, making
full use of the extraordinary data available in
Denmark and other Scandinavian countries.
Incorporating clinical information about
cause of death might clarify whether the
observations concern clinically severe cases,
or represent other factors, not related to the
gastrointestinal infection.
Sarah J O’Brien head of gastrointestinal diseases
division
Health Protection Agency, Communicable Disease
Surveillance Centre, London NW9 5EQ
sarah.o’brien@hpa.org.uk
Roger A Feldman emeritus professor of clinical
epidemiology
Barts and the London, Queen Mary School of
Medicine and Dentistry, University of London
E1 2AD
Competing interests: RAF reviewed published
and unpublished epidemiological data relating
to campylobacter on behalf of Bayer for an
administrative hearing involving Bayer and the
US Food and Drug Administration’s centre for
veterinary medicine.
1 Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Short and
long term mortality associated with foodborne bacterial
gastrointestinal infections: registry based study [commen-
tary by Evans]. BMJ 2003;326:357-360. (15 February.)
2 Aranda-Michel J, Gianella RA. Acute diarrhea: a practical
review. Am J Med 1999;106: 670-6.
3 Chapman PA, Siddons CA, Manning J, Cheetham C. An
outbreak of infection due to verocytotoxin-producing
Escherichia coli O157 in four families: the influence of
laboratory methods on the outcome of the investigation.
Epidemiol Infect 1997;119:113-9.
4 Tam CC,Rodrigues LC,O’Brien SJ. The study of infectious
intestinal disease in England: What risk factors for presen-
tation to general practice tell us about potential for
selection bias in case-control studies of reported cases of
diarrhoea. Int J Epidemiol (in press).
Mechanism needs to be explained
Editor—Helms et al show that gastroenteri-
tis due to one of four common bacterial
pathogens increases nearly three times the
likelihood of death within a year, even after
certain comorbidities are controlled for.1
There seems intuitively no reason why a
clinically self limiting acute gastroenteritis
should cause death except (unusually) as an
immediate result of the infection. Could the
people at greatest risk of these infections
have a lifestyle of dependence on fast food
and unsatisfactorily cooked or stored food
that is associated with greater mortality?
Were Helms et al able to compare the
lifestyles of their patients and their controls
in a way that might show relative social dep-
rivation? Or do the authors think that these
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four infections may cause death by some
specific mechanism in the subsequent 12
months? If so, can they suggest what it is?
Philip P Mortimer director
Sexually Transmitted and Blood Borne Virus
Laboratory, Central Public Health Laboratory,
London NW5 5HT
Competing interests: None declared.
1 Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Short and
long term mortality associated with foodborne bacterial
gastrointestinal infections: registry based study. BMJ
2003;326:357. (15 February.)
Authors’ reply
Editor—Our study was unique because it
included patients with infectious gastro-
enteritis, by and large people who sought care
from their family doctor and had no severe
underlying illness. The concerns that O’Brien
and Feldman raise about bias introduced by
case selection is likely to be less relevant in
Denmark as the Danish counties reimburse
laboratory costs, and for epidemiological
reasons doctors often request stool speci-
mens. Our study was the first to determine
mortality while adjusting for background
mortality. This was pivotal because gastro-
intestinal infections often affect elderly
people. Furthermore, we adjusted for comor-
bidity by using data from the national
discharge registry. We applied the principles
described by Charlson et al,1 but calculated
new empirical weights based on the actual
survival rates of the large background
population. This approach was used to
ensure that the weights were valid and appro-
priate in the given context. This approach
takes care of most of the concerns expressed
by Cox. We also found excess mortality in the
subanalysis, when all individuals with under-
lying illness had been excluded.
Many acute infections, including food-
borne bacterial infections, are associated
with short term and long term complica-
tions. These include acute complications
such as severe dehydration, misdiagnosis of
abdominal cramps, leading to surgery, or
spread of the pathogens into the blood-
stream. Salmonellas are a well known cause
of focal and vascular infections.2 3 The
Guillain-Barré syndrome is a severe reactive
complication to a campylobacter infection.4
Although each of these events is uncom-
mon, taken together they may account for
our findings.
We agree with O’Brien and Feldman
that both the infecting dose and subtype of
bacterial species are of importance. In the
analyses we looked at the effect of specific
zoonotic salmonella serotypes. Beyond Sal-
monella enteritidis, S typhimurium, and S
dublin, we could not see any differences,
probably because the number of each of the
exotic serotypes was too small to see this.
Finally, antimicrobial drug resistance may be
associated with adverse public health
effects.5
The biological plausibility is supported
by the fact that our estimates are in line with
common knowledge of the different agents.
For example, mortality after salmonella
infection was higher than after campylo-
bacter infection, and in the group of
Salmonella infections, serotype dublin, known
to be invasive, was associated with a marked
excess mortality. Although long term mor-
tality was observed for Salmonella, Campylo-
bacter and Yersinia enterocolitica, the pro-
portion of deaths attributable to the
infection was highest in the acute phase. The
table was prepared based on the figures in
our table 2. The relative mortality has been
converted to the attributable proportion of
deaths among exposed, that is, a measure of
the probability of a death being related to
the gastrointestinal infection. In our opin-
ion, the pattern presented in the table makes
sense from a clinical point of view, and sup-
ports the notion that our findings are more
than artefacts.
Morten Helms research fellow
Pernille Vastrup statistician
Kåre Mølbak staff specialist
Statens Serum Institut, DK-2300 Copenhagen,
Denmark
Competing interests: KM reviewed data relating
to Campylobacter on behalf of US Food and Drug
Administration’s centre for veterinary medicine
for an administrative hearing concerning a
proposed withdrawal of the fluoroquinolone
enrofloxacin (Baytril, Bayer) for use in poultry.
Please note: Dr Feldman and Cox Associates
reviewed similar data on behalf of Bayer.
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2 Cohen JI, Bartlett JA, Corey GR. Extra-intestinal mani-
festations of salmonella infections. Medicine (Baltimore)
1987;66:349-88.
3 Lester A, Eriksen NH, Nielsen H, Nielsen PB, Friis-Møller
A, Bruun B, et al. Non-typhoid Salmonella bacteraemia in
Greater Copenhagen 1984 to 1988. Eur J Clin Microbiol
Infect Dis 1991;10:486-90.
4 Allos BM. Campylobacter jejuni infection as a cause of the
Guillain-Barré syndrome. Infect Dis Clin North Am
1998;12:173-84.
5 Travers K, Barza M. Morbidity of infections caused by
antimicrobial-resistant bacteria. Clin Infect Dis 2002;
34(suppl 3):S131-4.
Mortality in Swedish women
with cosmetic breast implants
Study found increased risk of suicides
and cancer deaths
Editor—The increased suicides and lung
cancers among implant patients reported by
Koot et al is consistent with a study by Brin-
ton et al at the US National Cancer
Institute.1 2 However, Brinton et al found an
increased risk of suicides and cancer deaths
compared with other patients having plastic
surgery.
If plastic surgery patients have more
psychological problems than the general
population, as Koot suggests, that would not
explain the difference between suicide rates
of breast augmentation patients compared
with other plastic surgery patients. There are
other, more likely explanations. Notably,
unlike most other plastic surgery patients,
implant patients suffer from well docu-
mented complications such as chronic pain
and implant breakage that increase in likeli-
hood every year. Our centre receives letters
every week from women whose implants are
broken and who cannot afford explant
surgery. Many of these women are quite des-
perate, especially when silicone is migrating
to other organs or causing pain or deformi-
ties. Even in countries with national health
care, these problems can be difficult to rem-
edy and could potentially cause an increase
in suicides.
A flaw of the Koot et al study is that it
included women who had breast implants
for less than one year, which weakens the
statistical power. In contrast, the Brinton et
al study included women who had breast
implants for at least eight years and found
increases in deaths from suicide, lung
cancer, and brain cancer compared with
plastic surgery patients who reported similar
smoking and lifestyle habits.
Diana Zuckerman president
National Center for Policy Research for Women
and Families, 1901 Pennsylvania Avenue, NW Suite
901, Washington, DC 20006, 202 223-4000, USA
dz@center4policy.org
Competing interests: None declared.
1 Koot VCM, Peters PHM,Granath F, Grobbee DE,Nyren O.
Total and cause specific mortality among Swedish women
with cosmetic breast implants: prospective study. BMJ
2003;326:527-8. (8 March.)
2 Brinton LA, Lubin JH, Burich MC, Colton T, Hoover RN.
Mortality among augmentation mammoplasty patients.
Epidemiology 2001;12:321-6.
Body dysmorphic disorder should be
considered
Editor—Koot et al reported an increased
risk of suicide among patients who had
received cosmetic breast implants.1 The
somatoform disorder known as body
dysmorphic disorder entails a preoccupa-
tion with a defect in appearance, and the
defect is either imagined, or, if a slight
physical defect is present, the patient’s con-
cern is markedly excessive with subsequent
impairment of social or occupational
functioning.2 The patient’s distress may lead
to suicidal ideation, suicide attempts, and
Mortality data among 48 857 patients infected with salmonella, campylobacter, shigella, and Yersinia
enterocolitica. Mortality is expressed as the cumulative mortality risk in a time interval after infection
and the proportion of these deaths attributable to the gastrointestinal infection
Species
Time since infection (days)
0-30 31-180 181-365
Mortality risk
per 1000
Attributable
proportion (%)
Mortality risk
per 1000
Attributable
proportion (%)
Mortality risk
per 1000
Attributable
proportion (%)
Salmonella 12.3 92 10.8 55 8.1 35
Campylobacter 2.7 80 5.0 46 4.1 26
Shigella 3.0 95 — NS — NS
Yersinia 1.7 72 3.5 60 — NS
NS=no significant excess mortality.
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completed suicide.2 3 It has been estimated
that between 6% and 15% of patients
having cosmetic surgery and dermatology
suffer from this disorder.2
Consequently, cosmetic surgeons should
seek psychiatric consultations preopera-
tively for the purpose of ruling out body
dysmorphic disorder and have it treated if
present. Perhaps only then can the elevated
suicide rate associated with breast implants
be diminished.
Jordan Klesmer assistant professor of psychiatry
New York University School of Medicine, North
Shore University Hospital, 400 Community Drive,
Manhasset, New York 11030, USA
jklesmer@nshs.edu
Competing interests: None declared.
1 Koot VCM, Peters PHM,Granath F, Grobbee DE,Nyren O.
Total and cause specific mortality among Swedish women
with cosmetic breast implants: prospective study. BMJ
2003;326:527-8. (8 March.)
2 Diagnostic and Statistical Manual of Mental Disorders, fourth
edition, text revision. Washington, DC: American Psychiatric
Association, American Psychiatric Press, 2000.
3 Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI.
Body dysmorphic disorder: 30 cases of imagined ugliness.
Am J Psychiatry 150:2:302-8.
“Evidence of absence” can be
important
Editor—Alderson and Chalmers are rightly
critical of those who make inappropriate
claims, but they are themselves guilty of this.1
Compare these statements: “It is never
correct to claim that treatments have no
effect or that there is no difference in the
effects of treatments”, and “Absence of
evidence is not evidence of absence.” The
first is the opening sentence of their paper,
the second is the title of a paper by Altman
and Bland that they cite in its support.2 The
two are mutually exclusive, because if the
first were true then there could never be
“evidence of absence.”
In describing their method, Alderson and
Chalmers specify that they only classified
statements as claiming no effect or no differ-
ence if they were without qualification about
clinical or statistical significance. Although
this could have been described more clearly, it
is reassuring, as it shows that they accept that
it is possible to have evidence of absence, even
if this contradicts their eye catching but
grossly overstated first sentence.
Clearly, one can have evidence for the
absence of an effect or of a difference. If
enough large, well designed studies were to
show that a medical treatment or an
exposure was unassociated with outcome,
this would be as clear as our knowledge
about cigarettes and lung cancer, or
statins and heart disease. In practice, it
would be unlikely for this to happen where
an association is thought not to exist, as
hypotheses implying the absence of an
effect do not generate large research
programmes, but this does not affect the
principle.
Michael Joffe reader in epidemiology
Imperial College London, St Mary’s Campus,
London W2 1PG
m.joffe@imperial.ac.uk
Competing interests: None declared.
1 Alderson P, Chalmers I. Survey of claims of no effect in
abstracts of Cochrane reviews. BMJ 2003;326:475.
(1 March.)
2 Altman DG,Bland JM.Absence of evidence is not evidence
of absence. BMJ 1995;311:485.
Routine telephone review of
asthma
Measurement of quality dimensions
causes concern
Editor—The study by Pinnock et al on rou-
tine telephone review of asthma can be con-
sidered from the perspective of perform-
ance on the quality dimensions of
appropriateness, accessibility, efficiency,
safety, effectiveness, and acceptability.1–3 This
study indicated that, without clinical disad-
vantage or loss of satisfaction, telephone
consultations provided an efficient option
for the routine review of asthma.1 These
findings require further consideration.
The sample does not seem representative
of the target population. This is important
because the assessment of care is dependent
on the group studied.3 In addition to the
authors’ concerns about generalisability, our
concerns are that 75% of eligible patients did
not participate and recruitment was unequal
between groups. As such, appropriateness
and effectiveness for the target population
cannot validly be determined.
Measures emphasised patients’ percep-
tions. This can produce a biased perspec-
tive.3 Furthermore the proportion of
patients who withdrew may indicate dissatis-
faction not measured in the study and total
time of telephone review was not measured.
The quality of data to determine that
telephone consultation improved efficiency,
access, acceptability, and effectiveness of
care is questionable.
Accepted and prescribed standards of
clinical practice, such as peak flow measures,
were not performed in telephone interviews.
This may compromise the appropriateness
and safety of care. Lack of this data and
dependence on patient feedback challenges
the conclusion of no clinical disadvantage
between groups.
Measuring and improving quality is a
focus in health sectors. This study provided
an example of the difficulty and challenge in
measuring and assessing quality of health
services.2 3
Thanh Huynh coordinator
Parkdale Community Rehabilitation Centre,
Southern Health, Victoria, Australia
tnhuynh10@yahoo.com
Catherine Lavars project officer
Department of Human Services, Melbourne,
Victoria, Australia
Competing interests: None declared.
1 Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price
D, Sheikh A. Accessibility, acceptability, and effectiveness in
primary care of routine telephone review of asthma: prag-
matic, randomised controlled trial. BMJ 2003;326:477-9.
(1 March.)
2 De Geyndt W. Chapter 1: Definition, objectives and ration-
ale. Managing the quality of health care in developing
countries. World Bank Technical Paper Number 258,
1995:2-6.
3 Donabedian A. The quality of care: how can it be assessed?
JAMA 1988;260:1743-8.
Further investigation is required
Editor—Pinnock et al conclude that tele-
phone consultation for asthma review is an
efficient option for patients in primary care.1
We have several concerns about this study.
Firstly, a large number of patients (654/
932) chose not to take part, and a further
307 were excluded for other reasons. It is
not inconceivable that patients who dislike
telephone consultations could have entirely
opted out even before the study started.
Secondly, the assumption that actual
observation of patients’ inhaler technique
and peak flow measurement is equivalent
to asking patients about their technique
or measurements causes concerns.
Patients commonly deny problems using
inhalers but often fail to demonstrate
effective usage.
Thirdly, the conclusion that both inter-
ventions were equally effective is somewhat
spurious since, using their own instrument.
neither intervention produced a difference
in outcome three months later. It might be
better to say both were equally ineffectual.
Lastly we found in our randomised con-
trol trial of telephone triage versus face to
face consultations for appointments on the
same day2 that one of the main differences
between the two types of consultation was
the undertaking of opportunistic health
promotion. It would have been interesting to
know if anything other than asthma
management (for example routine blood
pressure measurements) was going on in
these 20 minute appointments. We believe
that further investigation of these problems
is required before recommending this
method of managing asthma.
Brian McKinstry senior researcher
Community Health Sciences, Edinburgh University,
Edinburgh EH8 9DZ
David Heaney senior researcher
Highlands and Islands Health Research Institute,
University of Aberdeen, Beechwood Business Park
North, Inverness IV2 3ED
Jeremy Walker research fellow
Research Unit in Health, Behaviour and Change,
University of Edinburgh, Medical School,
Edinburgh EH8 9AG
Sally Wyke director, Scottish School of Primary Care
Lister Institute, Edinburgh EH8 9DR
Competing interests: None declared.
1 Pinnock H, Bawden R, Proctor S, Wolffe S, Scullion J, Price
D, Sheikh A. Accessibility, acceptability, and effectiveness in
primary care of routine telephone review of asthma:
pragmatic, randomised controlled trial. BMJ
2003;326:477. (1 March.)
2 McKinstry B, Walker J, Campbell C, Heaney D, Wyke S.
Telephone consultations to manage requests for same-day
appointments: a randomised controlled trial in two
general practices. Br J Gen Pract 2002;52:306-10.
Authors’ reply
Editor—We acknowledged in our discus-
sion that only a third of eligible patients par-
ticipated in our trial raising concerns about
generalisability. Having identified a group
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reluctant to attend asthma clinics, achieving
a high response rate to a postal invitation
was always going to be difficult. As detailed
in our paper, of the 307 excluded for other
reasons, 50% had chronic obstructive pul-
monary disease and were therefore not
eligible.
We were concerned about the barrier to
checking inhaler technique imposed by tele-
phone consultations and discussed the issue
at the study training meeting. The trial
nurses agreed on a pragmatic approach: if
asthma control was good there was little
need for concern, but if suboptimal control
was identified they considered poor inhaler
technique as a possible cause and could
arrange a surgery appointment. Our results
do not suggest detriment to those in the
telephone group but we agree this point
warrants further investigation.
We do not agree with Huynh and Lavars
that inability to perform a peak flow
compromises care. A one off peak flow
reading is of limited value in assessing the
control of a variable condition such as
asthma. We opted to use the three asthma
morbidity questions which are recom-
mended for monitoring control1 and which
are reflected in the Short-Q morbidity score.
Furthermore, we used validated patient
based outcomes (for example, the Juniper
mini asthma related quality of life question-
naire), which are used increasingly in clinical
trials.2 Surgery based outcome measures
would have discouraged recruitment among
reluctant attendees who would potentially
benefit from a telephone service.
Using the telephone alters the dynamics
of consultations,3 and we would echo
McKinstry et al’s call for further investiga-
tion.We believe, however, that our results are
encouraging and are likely to be of
considerable interest to clinicians concerned
about meeting quality targets for annual
reviews.4
Hilary Pinnock General Practice Airways Group
clinical research fellow
Department of General Practice and Primary Care,
University of Aberdeen, Foresterhill Health Centre,
Aberdeen AB25 2AY
hpinnock@gpiag-asthma.org
Robert Bawden general practitioner
Health Centre, Botesdale, Diss, Norfolk IP22 1DU
Stephen Proctor general practitioner
Clarendon Medical Centre, Hyde, Cheshire
SK14 2AQ
Stephanie Wolfe respiratory nurse
Thorpewood Surgery, Norwich, Norfolk NR7 9QL
Jane Scullion nurse consultant
Respiratory Unit, Glenfield Hospital, Leicester
LE3 9QP
David Price General Practice Airways Group professor
of primary care respiratory medicine
Department of General Practice and Primary Care,
University of Aberdeen
Aziz Sheikh NHS/PPP Foundation primary care
postdoctoral researcher
Department of Public Health Sciences, St George’s
Hospital Medical School, London SW17 0RE
1 The British Thoracic Society/Scottish Intercollegiate
Guideline Network. British guideline on the management
of asthma. Thorax 2003;58(suppl 1):i1-i94.
2 Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating
patient-based outcome measures for use in clinical trials.
Health Technol Assessment 1998;2:14.
3 Pettinari C, Jessop L. ‘Your ears become your eyes’: manag-
ing the absence of visibility in NHS Direct. J Advanced
Nursing 2001;36:668-75.
4 NHS Confederation, British Medical Association. New
GMS contract 2003: investing in general practice. London:
BMA, 2003.
Consumption of coffee during
pregnancy
Article raises more questions than it
answers
Editor—Wisborg et al’s article raises more
issues than it settles.1 Firstly, coffee contains
not only caffeine but a mixture of different
ingredients (milk, sugar, stabilisers, flavour,
and other alkaloids from coffee beans).
Attributing the result of drinking coffee to
just one constituent seems illogical. If
Wisborg et al want to prove what they
contend, they should contrast the group tak-
ing eight cups of ordinary coffee to those
taking eight cups of decaffeinated coffee.
Secondly, in many parts of the world, tea,
chocolate, and cola are consumed on a large
scale and in high doses, like traditional Chi-
nese tea in Hong Kong. Yet Hong Kong has
one of the lowest perinatal mortality rates in
the world. In Japan and China tea is
regarded as part of the healthy diet, to be
consumed regularly. The same also applies
to cola in America and many parts of the
world. So what will be the combined effect of
coffee, tea, chocolate, and cola should the
woman be drinking marginal amounts of
coffee (four to seven cups)?
One of the gold standards in establish-
ing causal relations between two factors is to
show the dose dependent relation. Wisborg
et al’s study showed that, statistically
speaking, there is a one off increase in
stillbirth after eight or more cups of coffee.
To illustrate the dose dependent relation
better, the last group should have been sub-
divided into those taking eight to 11 cups,
and those taking 12 cups or more.
Caffeine is used widely to treat migraines.
If caffeine leads to stillbirth in the form of
coffee, it may carry the same risk for women
taking it for their migraine. Should we ban
women from taking this seemingly harmless
drug lest caffeine leads to stillbirth?
Lastly, I have doubts about the estimates
of the number of cups of coffee per day (and
hence the dose of caffeine). The size of the
cup and the extent to which a cup is filled all
affect the actual amount of coffee taken as
does the brand. So how accurate can your
estimate be?
Ludwig Tsoi senior medical officer
Accident and Emergency Department, North
District Hospital, Hong Kong SAR
doctor@cuhk.edu.hk
Competing interests: LT is a coffee, tea,
chocolate, and cola lover.
1 Wisborg K, Kesmodel U, Hammer Beck B, Hedegaard M,
Brink Henriksen T. Maternal consumption of coffee
during pregnancy and stillbirth and infant death in first
year of life: prospective study. BMJ 2003;326:420-2.
(22 February.)
Authors should adjust for history of
drug abuse
Editor—We read with interest the article of
Wisborg et al.1 The authors support that
high maternal coffee consumption during
pregnancy is associated with an increased
risk of stillbirth but not with infant death.
They mention that women with a high
intake of coffee are more likely to be smok-
ers and to have a high intake of alcohol.
They correctly adjusted their results for
smoking and drinking habits. However, they
do not provide any information about drug
abuse among these women.
Consumption of eight or more cups of
coffee is suggestive of addictive behaviour.
The use of illegal drugs such as cocaine is
associated with an increased incidence of
parallel cigarette and alcohol use.2 3 The
adverse effect of maternal use of heroin,
cocaine, crack cocaine, and benzodiazepines
in pregnancy has been adequately
documented.3–5 The use of cannabis may not
be a major prognostic factor regarding the
outcome of pregnancy but is an indicator of
low socioeconomic status and use of other
harmful drugs.2
The authors draw the profile of preg-
nant women who consume high amounts of
coffee. They tend to be older, more often
multiparous, more likely to be single, less
likely to be students, and they had fewer
years of education. Interestingly this descrip-
tion matches with the profile of drug users.3 4
For the above reasons we believe that the
exclusion of the information of drug abuse
from the study is a methodological error.
Michael Sindos clinical research fellow
sindosgyn@hotmail.com
Narendra Pisal clinical research fellow
Department of Women’s Health, Whittington
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Data do not support claim
Editor—Wisborg et al found an association
between maternal coffee consumption and
risk of stillbirth, and claim that after
adjustment for potential confounding fac-
tors the association remained significant.1
However, I am not convinced that the data
they present support that claim.
The claim of a significant association
seems to be based on the statistical
significance for the odds ratio that compares
the highest consumption group with the
Letters
1268 BMJ VOLUME 326 7 JUNE 2003 bmj.com
zero consumption group. This odds ratio is
in any case only marginally significant at the
5% level, as the 95% confidence interval
extends as far as 1. More importantly,
Wisborg et al do not present the results
of an overall test of differing risk of still-
birth among all the coffee consumption
groups.
From a statistical point of view, it is not
good practice to rely on pairwise compari-
sons between specific groups if the overall
group effect is not significant. We are not
told whether it is significant or not, but
given that neither the low nor medium con-
sumption group differs from the zero
consumption group, and the high con-
sumption group differs only marginally
from the zero consumption group; my
guess is that it isn’t.
Adam Jacobs director
Dianthus Medical Limited, London SW19 3TZ
ajacobs@dianthus.co.uk
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Authors’ reply
Editor—In a prospective study we found
that coffee drinking during pregnancy was
associated with an increased risk of stillbirth,
but not with death in infancy.1 Our results on
stillbirth seemed to indicate a threshold
effect around four to seven cups per day, but
the risk estimate in women with the highest
intake of coffee was based on only 11
stillbirths and we therefore had no possibility
to explore further the relation between
coffee and stillbirth in women drinking eight
or more cups of coffee per day. Ludwig
claims that a dose dependent association is
the gold standard for establishing a causal
relation. This is not correct. A monotonic,
unidirectional dose-response curve is neither
necessary nor sufficient for establishing a
causal relation.2
Our result may represent a causal
relationship or be due to other factors asso-
ciated with coffee drinking and stillbirth.
Sindos et al are particularly concerned
about the possibility of unadjusted con-
founding, because no information was
included about drug abuse. Drug abuse,
especially of cocaine, among pregnant
women, is fortunately a minor problem in
Denmark and identified drug abusers are
not included in our cohort.3 Drug abuse
including cocaine is thus of little or no
relevance as a confounder in our cohort.
Caffeine is regarded as the key com-
ponent in studies of the potential effects of
coffee. The path to death is usually
multifactorial, composed of several com-
ponent causes.2 Caffeine may just be one
causal component that in some settings
together with other causal components
leads to death but in other settings one or
more of the other component causes are
missing, or the time specific distribution of
these component causes is different.
As for Jacobs’s criticism of our statistical
approach we believe that pairwise compari-
sons between each level of coffee intake and
the reference category is technically appro-
priate, even if other approaches could have
been chosen. Coffee is a commonly
consumed stimulant and if our results
represent a true causal relationship it has
important health implications. However,
the question on a causal relation is still
open. Thus in an ongoing randomised
study including 1000 pregnant women we
are further exploring the effect of coffee
with and without caffeine.
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Doctors as servants of patients
Long term patients are underused
resource
Editor—Your coverage of Ian Kramer’s
contribution to the debate raised by the
chief medical officer1 is useful if slightly
inaccurate (Kramer is a former vice chair-
man of our organisation). The relationship
between provider and servant is too old
fashioned for the modern world. We are
partners in the shared care of the individual
patient, which involves other health profes-
sionals too. Other patients can have an
important role in explaining, empathising,
listening, advocating, and much more.
Long term patients as repeated users of
the healthcare system are an incredibly
underused resource in how that system
works for, or sometimes against, them. If
the input of patients as participants is to be
valued, perhaps it should be paid for, but
we would be half way there if this was,
firstly, encouraged; secondly, resourced; and,
most importantly, were it ever listened to
and acted on at a higher level than the
colour of the new and overdue upholstery
or curtains.
Bernard Forbes chairman
UK Coalition of People Living with HIV and AIDS,
London SE11 5RD
(www.ukcoalition.org, www.positivenation.co.uk)
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Surely we can do better than this
Editor—Given the context of the modern
healthcare market, and our developed
appreciation of dynamics between patients
and doctors, the comments of Professor
Liam Donaldson seem a little trite and
superficial.1 The welfare of the patient may
be our concern, but so is the welfare of all of
our patients. Similarly, as professionals, we
have a duty to do good to society in general,
just as we have a duty to truth and
intellectual honesty.
Reducing these complexities to the
feudal simplicity of a “master-servant”
relationship demeans both participants, just
as ignoring the role of patients in setting the
political and practical agenda (not least
through the ballot box—when did we as a
society last elect a government with a
mandate to raise taxes?) diminishes their
responsibility in the medical world that
follows. Donaldson may regard us as our
patients’ servants. I hope that he does not
forget that, as an administrator and political
appointee, he is ours.
Kiaran Asthana general practitioner
Lakeside Medical Centre, Perton, Wolverhampton
WV6 7PD
kiaran@doctors.org.uk
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Modesty may be deceptive
Editor—Professor Liam Donaldson is right
in his sentiments, if impolitic in their expres-
sion.1 However, I would rather express my
own humility than have it expressed on my
behalf. I suspect this would apply to most of
my colleagues. Given our respective roles, it
may be for me to assert that I am a servant of
my patients, and for Donaldson to assert
that he is the servant of the government.
Even then, protestations of modesty deserve
a cynical scrutiny. Who better than Swift to
provide one?
“Our betters tell us they are our humble
servants, but understand us to be their slaves.”
John F Morgan senior lecturer in liaison psychiatry
St George’s Hospital Medical School, London
SW170RE jmorgan@sghms.ac.uk
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